Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate which method of naltrexone induction during rapid opioid detoxification causes stronger stress response and has a higher influence on opioid abstinence caused by opioid induction.


Clinical Trial Description

Study enrolls opiate addicted patients who are motivated for a long term treatment and full opiate abstinence. Patient is offered to take part in a study. Information is provided regarding protocol, aim and course of study. Patients who are eligible and consent for study commit to follow the pre-study recommendations.

Study consists of:

Primary assessment - information about study. Assessment of patient according to predefined criteria. Consent form. Allocation of the treatment date.

Stabilization - Buprenorphine. Assessment according to SOWS and OWS. Total amount of buprenorphine is recorded.

Repeated evaluation - patient after successful stabilization course undergoes urine test for psychotropic substances, blood alcohol level is recorded. If any test is positive patient is not enrolled to study.

Correction of opioid withdrawal symptoms - all of the patients receive medicines for opioid detoxification, infusion therapy in predefined doses.

Antagonist induction - patients receive opioid antagonist (incremental or standard dose). Withdrawal symptoms are assessed and correction with lorazepam is given if needed.

Data collection - data is recorded (demographic, epidemiological, vital signs, opioid withdrawal symptoms, levels of hormones, metabolites, electrolytes). ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02362256
Study type Interventional
Source Vilnius University
Contact
Status Completed
Phase N/A
Start date May 2014
Completion date September 2014

See also
  Status Clinical Trial Phase
Completed NCT02539823 - Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans Phase 2
Recruiting NCT01934751 - Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction N/A
Completed NCT00913770 - Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department N/A
Completed NCT00929253 - Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II) N/A
Terminated NCT02741076 - Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain Phase 4
Completed NCT03015597 - Pilot Study of Contingency Management for Smoking Cessation N/A
Completed NCT02571400 - Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study N/A
Terminated NCT00552578 - Buprenorphine as a Treatment in Opiate Dependent Pain Patients Phase 4
Completed NCT00253890 - Insomnia and Drug Relapse Risk Phase 3
Completed NCT02667158 - A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion
Completed NCT02667210 - Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review
Active, not recruiting NCT01021566 - Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis Phase 3
Withdrawn NCT01015066 - Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents Phase 4
Completed NCT02660619 - Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication
Active, not recruiting NCT02751762 - A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
Completed NCT02657148 - Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
Completed NCT01605539 - Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans Phase 2
Completed NCT00204243 - Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services Phase 2
Completed NCT02667262 - An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data
Completed NCT00829777 - Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects Phase 1